Get a glimpse into our company and investor data—powered by the PitchBook Platform
Provider of antibiotics. The business unit is an anti-bacterial programme which includes broad-spectrum antibiotic GC-072, which is being developed with US government bio-defense funding.
You’re viewing a free company profile from the PitchBook Platform. To explore Evolva (EV-035 Series)’s full profile, request a free trial.
© 2019 PitchBook Data. All rights reserved. PitchBook is a financial technology company that provides data on the capital markets.